Klingel acquires MedTech companies Bächler Feintech and Gehring Cut with the support of IK Investment Partners

Klingel medical metal group (“Klingel”), owned by the IK VIII Fund, announce that it has completed the acquisitions of Bächler Feintech AG (“Bächler”) and Gehring Cut AG (“Gehring”). Both companies are leading manufacturers of high-precision surgical instruments for the global MedTech market.

Bächler was founded in 1964 and employs 140 people at the production site in Hölstein, Switzerland, where state-of-the-art machinery and industry-leading quality management are established.

Gehring was founded in 1948 and employs 75 people at the production site in Matzingen, Switzerland, where similar to Bächler, a state-of-the-art machine park and industry-leading quality management are established.

Through these acquisitions, Klingel strengthens its position as the leading pan-European MedTech CMO for complex components and instruments. The extended platform enables the combined group to provide its broad global customer base with a more flexible service to meet their customers’ high quality requirements and to serve their ever-increasing demands.

“With Bächler and Gehring we have found the perfect complements to our MedTech platform. Through the acquisitions, we are gaining additional blue-chip customers, manufacturing capabilities and valuable expertise for our group, enabling us to create real value-add for our customers. In addition, we have found strong partners in the management teams of Bächler and Gehring and look forward to our next phase of growth as a larger pan-European group”, said Ralf Petrawitz, CEO of Klingel.

For further questions, please contact:

KLINGEL medical metal
Ralf Petrawitz, CEO
Phone: +49 7231 6519 0

IK Investment Partners
Anders Petersson, Partner
Phone: +49 40 369 8850 

Mikaela Murekian, Director Communications & ESG
Phone: +44 77 87 573 566
mikaela.murekian@ikinvest.com